Inventor
NITSCH ROGER
CH28 patents
⚠️ This page may combine multiple inventors who share the name “NITSCH ROGER”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BIOGEN INT NEUROSCIENCE GMBH
8 patentsUS9896504B2Feb 20, 2018
Human anti-alpha-synuclein antibodies
BIOGEN INT NEUROSCIENCE GMBH8 citations83
US9605059B2Mar 28, 2017
Human anti-tau antibodies
BIOGEN INT NEUROSCIENCE GMBH12 citations83
US10259866B2Apr 16, 2019
TDP-43 specific binding molecules
BIOGEN INT NEUROSCIENCE GMBH7 citations81
US9587014B2Mar 7, 2017
TDP-43 specific binding molecules
BIOGEN INT NEUROSCIENCE GMBH7 citations81
US10301381B2May 28, 2019
Anti-alpha synuclein binding molecules
BIOGEN INT NEUROSCIENCE GMBH4 citations71
US9975947B2May 22, 2018
Anti-alpha synuclein binding molecules
BIOGEN INT NEUROSCIENCE GMBH4 citations71
US11091540B2Aug 17, 2021
TDP-43 specific binding molecules
BIOGEN INT NEUROSCIENCE GMBH0 citations59
US10703808B2Jul 7, 2020
Human anti-alpha-synuclein antibodies
BIOGEN INT NEUROSCIENCE GMBH0 citations51
UNIV ZUERICH
4 patentsUS9828420B2Nov 28, 2017
Method of providing disease-specific binding molecules and targets
UNIV ZUERICH14 citations91
US10202445B2Feb 12, 2019
Method of providing disease-specific binding molecules and targets
UNIV ZUERICH7 citations83
US8022268B2Sep 20, 2011
Transgenic animal model for alzheimer's disease
UNIV ZUERICH5 citations54
US7550648B2Jun 23, 2009
Inducing neurofibrillary tangles in transgenic mice expressing a mutant tau protein
UNIV ZUERICH0 citations51